CD8A and myeloid sarcoma: For determining the pathological function of CD8 + T cells in MS progression, GzmB level was measured in peripheral CD8 + T cells of our involved MS patients and HD, by comparing with HD and RRMS patients, GzmB level was found significant up-regulation in CD8 + T cells from SPMS patients (Fig. 4A).